PRESS RELEASE published on 11/06/2023 at 17:40, 2 years 11 months ago Valbiotis : Déclaration mensuelle du nombre d’actions et droits de vote – Octobre 2023
PRESS RELEASE published on 10/04/2023 at 17:40, 3 years ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
PRESS RELEASE published on 10/02/2023 at 17:40, 3 years ago VALBIOTIS SA: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes
PRESS RELEASE published on 10/02/2023 at 17:40, 3 years ago VALBIOTIS SA : l’étude de Phase II/III REVERSE-IT sélectionnée pour une présentation orale au congrès 2023 de l’EASD, principale société savante européenne pour le diabète
PRESS RELEASE published on 09/28/2023 at 17:40, 3 years ago Valbiotis publishes its financial report for the first half of 2023 and confirms its strategic roadmap
PRESS RELEASE published on 09/28/2023 at 17:40, 3 years ago Valbiotis publie son rapport financier pour le premier semestre 2023 et confirme sa feuille de route stratégique
PRESS RELEASE published on 09/11/2023 at 17:40, 3 years 1 month ago VALBIOTIS SA: Valbiotis presents the full results of the Phase II/III REVERSE-IT study: impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes
PRESS RELEASE published on 09/11/2023 at 17:40, 3 years 1 month ago VALBIOTIS SA: Valbiotis présente les résultats complets de l’étude de Phase II/III REVERSE-IT : efficacité remarquable de TOTUM•63 contre le prédiabète et les stades précoces du diabète de type 2
PRESS RELEASE published on 09/06/2023 at 17:40, 3 years 1 month ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Juillet 2023
PRESS RELEASE published on 09/06/2023 at 17:40, 3 years 1 month ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Août 2023
Published on 10/19/2026 at 14:30, 7 hours 29 minutes ago Core Silver Intersects Copper Bearing VMS Mineralization at the Touleary Project
Published on 10/19/2026 at 14:00, 7 hours 59 minutes ago Four Nines Gold Intersects 80.1 Meters Averaging 1.08 g/t Gold in Expanding Lower Telegraph Corridor at Hayden Hill
Published on 10/19/2026 at 13:30, 8 hours 29 minutes ago Empress Announces Closing of Tongon Gold Stream Investment and Debt Financing
Published on 10/19/2026 at 13:30, 8 hours 29 minutes ago Mako Mining Announces Q3 2026 Production Results with Gold Recovered of 12,743 oz Au (Sales of 11,581 oz Au), and Positive Permitting Updates at Mt. Hamilton and San Albino
Published on 10/19/2026 at 13:01, 8 hours 58 minutes ago CoTec Holdings Corp. Notes HyProMag USA Deployment of Mobile Inserma System, Extending Hard Disk Drive Processing to Customer Sites Across the United States
Published on 10/19/2026 at 21:22, 36 minutes ago EQS-Adhoc: Cantourage Group SE: Supervisory Board Resolves to Transition to IFRS Following First-Time Requirement to Prepare Consolidated Financial Statements
Published on 10/19/2026 at 19:00, 2 hours 59 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 12/10/2026 au 16/10/2026
Published on 10/19/2026 at 18:05, 3 hours 53 minutes ago Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation
Published on 10/19/2026 at 17:45, 4 hours 14 minutes ago VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions
Published on 10/19/2026 at 17:45, 4 hours 14 minutes ago VALBIOTIS SA: Valbiotis doublement récompensé « Meilleur Produit Pharma 2027 » pour ses solutions ValbiotisPRO® Cholestérol et ValbiotisPRO® Santé Métabolique
Published on 10/19/2026 at 19:00, 2 hours 59 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 : Compte rendu et résultat des votes - Évolution de la gouvernance
Published on 10/19/2026 at 18:40, 3 hours 19 minutes ago Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Published on 10/19/2026 at 18:40, 3 hours 19 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 12 et 13 octobre 2026
Published on 10/19/2026 at 18:00, 3 hours 59 minutes ago WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Published on 10/19/2026 at 18:00, 3 hours 59 minutes ago L’OMS accorde une autorisation d’utilisation d’urgence au test BIOFIRE® Global Fever Special Pathogens, élargissant l’accès au diagnostic différentiel face à l’épidémie d’Ebola
